PuREC Co.
Latest round
- Series C
Last raised
- Mar 2022
Total raised
- $12M
Investors
- 6
About PuREC Co.
, Ltd., Ltd. specializes in the cultivation of high-purity MSCs for therapeutic applications.PuREC is focused on developing and commercializing high-purity mesenchymal stem cells under the brand name Rapidly Expanding Cells (REC).PuREC generates revenue through the sale of high-purity MSCs and related services tailored for clinical applications. Their B2B model serves hospitals and research institutions that procure MSCs for clinical studies. The funds will be directed towards developing new MSC products and advancing their research capabilities.
Who invested in PuREC Co.
6 investors across 3 rounds
See all investors in PuREC Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PuREC Co.
Who invested in PuREC Co.?
PuREC Co. has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PuREC Co. raised?
PuREC Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did PuREC Co. last raise money?
PuREC Co.'s most recent round on record is a Series C, in Mar 2022.
What does PuREC Co. do?
PuREC Co. is a biotechnology company.
Where is PuREC Co. headquartered?
PuREC Co. is headquartered in Izumo-shi, Japan.
Which VCs invest in companies like PuREC Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at PuREC Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like PuREC Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.